Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
MPN-223: Hope or Hazard? The Safety Profile of Roxadustat in Patients With Anemia — Ahmet Sarıcı (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
MPN-223: Hope or Hazard? The Safety Profile of Roxadustat in Patients With Anemia
LT
Shared by
Lokman Hekim Tanrıverdi
İnönü University
MPN-223: Hope or Hazard? The Safety Profile of Roxadustat in Patients With Anemia
Article
2025
en
Authors
+1 more
AS
Ahmet Sarıcı
HB
Hı Bayram Berktas
ME
MehmetAli Erkurt
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
EFFICACY OF ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS WITH ANEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Lokman Hekim Tanrıverdi
,
Ayşe Uysal
,
Arzu Akyay
,
Yurday Öncül
,
Ahmet Sarıcı
Letter
2007
Pre-emptive/early intervention with triptans in migraine: hope, hype and hazard
In Memory of Vinod Kumar Gupta
International Journal of Clinical Practice
Letter
2009
SCOUT Trial Reports on the Safety Profile of Sibutramine in Patients with Cardiovascular Diseases
Aldo Maggioni
Article
2022
Oral Anticoagulant Use for Patients with Atrial Fibrillation with Concomitant Anemia and/or Thrombocytopenia
Yung‐Hsin Yeh
,
Yi‐Hsin Chan
,
Shao‐Wei Chen
,
Shang‐Hung Chang
,
Chunli Wang
,
Chi‐Tai Kuo
,
Professor Gregory Lip
,
Shih‐Ann Chen
,
Tze‐Fan Chao
Article
2000
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus
Styliani I. Kokori
,
John P A Ioannidis
,
Michalis Voulgarelis
,
Athanasios G. Tzioufas
,
Haralampos Μ. Moutsopoulos
Discussion(0)
No comments yet. Be the first to comment.